Simple Summary There is accumulating evidence that gut microbiome dysbiosis is
associated with the etiopathogenesis of nonalcoholic fatty liver disease (NAFLD), from the …

Background The human intestinal microbiota is a key regulator of host metabolic and
immune functions and alterations in the microbiome ('dysbiosis') have been implicated in …

The number of articles on the relationships between the intestinal microbiota and liver
diseases has continued to increase. The aim of this study was to assess publications on this …

Recent breakthrough in our understanding pertaining to the pathogenesis of nonalcoholic
fatty liver disease (NAFLD) has pointed to dysregulation or derangement of the gut …

Perturbations in microbial abundance or diversity in the intestinal lumen leads to intestinal
inflammation and disruption of intestinal membrane which eventually facilitates the …

Nonalcoholic fatty liver disease (NAFLD) is leading chronic liver syndrome worldwide. Gut
microbiota dysbiosis significantly contributes to the pathogenesis and severity of NAFLD …

Non‑alcoholic fatty liver disease (NAFLD), the most prevalent chronic liver disease in the
world, is affected by numerous extrinsic and intrinsic factors, including lifestyle, environment …

Nonalcoholic fatty liver disease (NAFLD) is the most frequent liver disease worldwide. Gut
microbiota can play a role in the pathogenesis of NAFLD since dysbiosis is associated with …

Non-alcoholic fatty liver disease (NAFLD) is a common and serious disease. Literature
reports the central role of the gut-liver axis in the pathogenesis of NAFLD, and recently …

The incidence of nonalcoholic fatty liver disease (NAFLD) continues to increase with
prevalence estimates ranging from 17%–33%, making it is the most common cause of …